Immunological Targets in Generalized Myasthenia Gravis Treatment: Where Are We Going Now?

Brain Sci · 2025 · PMC12468546 · PMID 41008338

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, while the AChR+ subgroup also showed significant improvements in QMG, the difference in QMG score for the MuSK+ subgroup did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.